PGE2-Induced IDO1 Inhibits the Capacity of Fully Mature DCs to Elicit an In Vitro Antileukemic Immune Response
In the last years, dendritic cells (DC) have been evaluated for antitumor vaccination. Although DC-based vaccines have raised great expectations, their clinical translation has been largely disappointing. For these results, several explanations have been proposed. In particular,...
Saved in:
| Main Authors: | Sara Trabanelli, Mariangela Lecciso, Valentina Salvestrini, Michele Cavo, Darina Očadlíková, Roberto M. Lemoli, Antonio Curti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2015/253191 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SYNTHETIC QUINAZOLINONES AS NEW ANTILEUKEMIC AGENTS
by: Giorgio Antoniolli, et al.
Published: (2025-05-01) -
Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction Therapy in Acute Myeloid Leukemia Patients
by: Valentina Salvestrini, et al.
Published: (2025-02-01) -
Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2
by: Candice Sakref, et al.
Published: (2025-03-01) -
Antileukemic impact of glucocorticoid use in acute lymphoblastic leukaemia treatment
by: Meri A. Shervashidze, et al.
Published: (2023-08-01) -
Phytochemical Investigation of Egyptian Riverhemp: A Potential Source of Antileukemic Metabolites
by: Shimaa M. Abdelgawad, et al.
Published: (2022-01-01)